ArticleAdvances in experimental medicine and biology2021
Health-Related Quality of Life and Living Costs of HIV-Infected Patients.
Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe aim of this study was the evaluation of health-related quality of life (HRQoL) of HIV-infected patients and the effect of their illness in their living costs. MATERIAL AND
methodThis is a cross-sectional study and the study sample, which was a sample of convenience, included 98 HIV-infected patients from March to May 2019 at the General Oncology hospital "Oi Agioi Anargyroi" in Greece. The main tools of the survey were the Greek version of the MOS-HIV and a questionnaire used for measuring rehabilitation costs in trauma patients adjusted for the needs of the this study.
resultsA total of 98 patients were inducted in our study aged 49.3 ± 11.3 years, most of them males (68.3%). HRQoL was assessed in 11 individual dimensions. The highest score was found in the dimensions of role functioning (73.47 ± 36.93), physical functioning (72.53 ± 26.65), and social functioning (71.63 ± 32.3). Regarding the patients' living costs over the last month due to their illness, the highest burden comes from other expenses (152.4 ± 179.5), services provided by a psychologist (142.8 ± 170.6) and medical visits (142.8 ± 170.6).
conclusionsAs the HIV infection is characterized as a chronic disease, the economic cost due to the illness needs to be studied as it affects the extent to which an HIV-infected patient can access medical care and meet emerging needs. Therefore, future research should focus in the economic dimension of the illness in relation with the quality of life of these patients and their relatives, so that new health policies may arise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.